About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Procedure for reviewingReviewers 2023-2024
About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Procedure for reviewingReviewers 2023-2024
Logout
Obstetrics and Gynegology2021№6
Placenta increta: Evolution of knowledge...

Placenta increta: Evolution of knowledge and skills

DOI
https://dx.doi.org/10.18565/aig.2021.6.34-40

Lisitsyna O.I., Nizyaeva N.V., Mikheeva A.A.

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation, Moscow, Russia
Objective. To investigate the current possibilities of diagnosis and prognosis of placenta increta and the most effective organ-sparing treatments for this condition according to data from Russian and foreign literature.
Materials and methods. The keywords “placenta”, “placenta increta”, “PAS”, “organ-sparing treatment”, “accreta”, “increta”, “percreta” were used to search for literature sources in the Russian and foreign databases: eLibrary, Medline/PubMed, Embase, CINAHL. Forty sources were selected.
Results. The pioneering scientists Irving and Hertig defined the term “placenta increta” as “abnormal partial or complete attachment of the placenta to the uterine wall.” There are presently several grades of placenta accreta spectrum (PAS): 1) placenta adherenta or creta (the tight attachment or fusion of the placenta to the muscle layer); 2) placenta increta (villous invasion into the muscle layer); 3) placenta percreta (placental invasion into all uterine layers). Clinically abnormal attachment of the placenta manifests itself in its inability to separate from the uterine wall (as it normally does). The most significant risk factors for this abnormality include prior uterine surgery, placenta previa, and a history of PAS. For diagnosis, ultrasound and magnetic resonance imaging, which have equal efficiency, are used. Preference for surgical treatment is given to organ-sparing methods that can save not only the life of a mother, but also her reproductive function.
Conclusion. Placenta increta is a dangerous pregnancy complication that leads to massive blood loss and high maternal morbidity and mortality rates. To date, a significant number of studies have been conducted to investigate this problem and to elaborate effective management tactics for these patients. The paper identifies the features of terminology, epidemiology, possible risk factors, and molecular markers and attributes of the pathogenesis of this nosological entity. It describes in details the most effective organ-sparing treatments for placenta increta.

Keywords

placenta
placenta increta
PAS
cytotrophoblast invasion
markers
surgical treatment
organ-sparing treatment
accreta
increta
percreta
Full text (in Russian)

References

  1. Irving C., Hertig A.T. A study of placenta accreta. Surg. Gynecol. Obstet. 1937; 64: 178-200.
  2. Jauniaux E., Jurkovic D. Placenta accreta: Pathogenesis of a 20th century iatrogenic uterine disease. Placenta. 2012; 33(4): 244-51. https://dx.doi.org/10.1016/j.placenta.2011.11.010.
  3. Jauniaux E., Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2017; 217(1): 27-36. https://dx.doi.org/10.1016/j.ajog.2017.02.050.
  4. Jauniaux E., Ayres-de-Campos D., Langhoff-Roos J., Fox K.A., Collins S.; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int. J. Gynaecol. Obstet. 2019; 146(1): 20-4. https://dx.doi.org/10.1002/ijgo.12761.
  5. Carusi D.A. The placenta accreta spectrum: Epidemiology and risk factors. Clin. Obstet. Gynecol. 2018; 61(4): 733-42. https://dx.doi.org/10.1097/GRF.0000000000000391.
  6. Clark S.L., Koonings P.P., Phelan J.P. Placenta previa/accreta and prior cesarean section. Obstet. Gynecol. 1985; 66: 89-92.
  7. Silver R.M., Landon M.B., Rouse D.J., Leveno K.J., Spong C.Y., Thom E.A. et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet. Gynecol. 2006; 107(6): 1226-32. https://dx.doi.org/10.1097/01.AOG.0000219750.79480.84.
  8. Morlando M., Sarno L., Napolitano R., Capone A., Tessitore G., Maruotti G.M., Martinelli P. Placenta accreta: Incidence and risk factors in an area with a particularly high rate of cesarean section. Acta Obstet. Gynecol. Scand. 2013; 9(4)2: 457-60. https://dx.doi.org/10.1111/aogs.12080.
  9. Upson K., Silver R.M., Greene R., Lutomski J., Holt V.L. Placenta accreta and maternal morbidity in the Republic of Ireland, 2005-2010. J. Matern. Fetal Neonatal Med. 2014; 27(1): 24-9.https://dx.doi.org/10.3109/14767058.2013.799654.
  10. Eshkoli T., Weintraub A.Y., Sergienko R., Sheiner E. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am. J. Obstet. Gynecol. 2013; 208(3): 219.e1-7. https://dx.doi.org/10.1016/j.ajog.2012.12.037.
  11. Usta I.M., Hobeika E.M., Abu Musa A.A., Gabriel G.E., Nassar A.H. Placenta previa-accreta: risk factors and complications. Am. J. Obstet. Gynecol. 2005; 193(3, Pt.2): 1045-9. https://dx.doi.org/10.1016/j.ajog.2005.06.037.
  12. Bowman Z.S., Eller A.G., Bardsley T.R., Greene T., Varner M.W., Silver R.M. Risk factors for placenta accreta: A large prospective cohort. Am. J. Perinatol. 2014; 31(9): 799-804. https://dx.doi.org/10.1055/s-0033-1361833.
  13. Sentilhes L., Kayem G., Ambroselli C., Provansal M., Fernandez H., Perrotin F. et al. Fertility and pregnancy outcomes following conservative treatment for placenta accreta. Hum. Reprod. 2010; 25(11): 2803-10. https://dx.doi.org/10.1093/humrep/deq239.
  14. Washburn E.E., Pocius K., Carusi D. Outcomes of nonsurgical versus surgical treatment of cesarean scar pregnancies in the first trimester. Arch. Gynecol. Obstet. 2017; 296(3): 533-41. https://dx.doi.org/10.1007/s00404-017-4466-x.
  15. Seow K.M., Hwang J.L., Tsai Y.L., Huang L.W., Lin Y.H., Hsieh B.C. Subsequent pregnancy outcome after conservative treatment of a previous cesarean scar pregnancy. Acta Obstet. Gynecol. Scand. 2004; 83(12): 1167-72. https://dx.doi.org/10.1111/j.0001-6349.2004.00445.x.
  16. Gilliam M., Rosenberg D., Davis F. The likelihood of placenta previa with greater number of cesarean deliveries and higher parity. Obstet. Gynecol. 2002; 99(6): 976-80. https://dx.doi.org/10.1016/s0029-7844(02)02002-1.
  17. Karami M., Jenabi E., Fereidooni B. The association of placenta previa and assisted reproductive techniques: a meta-analysis. J. Matern. Fetal Neonatal Med. 2018; 31(14): 1940-7. https://dx.doi.org/10.1080/14767058.2017.1332035.
  18. Jauniaux E., Bhide A., Kennedy A., Woodward P., Hubinont C., Collins S.; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. Int. J. Gynaecol. Obstet. 2018; 140(3): 274-80. https://dx.doi.org/10.1002/ijgo.12408.
  19. Милованов А.П. Цитотрофобластическая инвазия — важнейший механизм плацентации и прогрессии беременности. Архив патологии. 2019; 81(4): 5-10. [Milovanov A.P. Cytotrophoblastic invasion is the most important mechanism of placentation and pregnancy progression. Archive of Pathology/Arkhiv patologii. 2019; 81(4): 5-10. (in Russian)].
  20. Shepherd A.M., Mahdy H. Placenta accreta. In: StatPearls. [Internet]. Treasure Island: StatPearls Publishing; 2020. Available at: https://www.ncbi.nlm.nih.gov/books/NBK563288/
  21. Bartels H.C., Postle J.D., Downey P., Brennan D.J. Placenta accreta spectrum: A review of pathology, molecular biology, and biomarkers. Dis. Markers. 2018; 3: 1507674. https://dx.doi.org/10.1155/2018/1507674.
  22. Goh W., Yamamoto S.Y., Thompson K.S., Bryant-Greenwood G.D. Relaxin, its receptor (RXFP1), and insulin-like peptide 4 expression through gestation and in placenta accreta. Reprod. Sci. 2013; 20(8): 968-80. https://dx.doi.org/10.1177/1933719112472735.
  23. Jabrane-Ferrat N., Siewiera J. The up side of decidual natural killer cells: New developments in immunology of pregnancy. Immunology. 2014; 141(4): 490-7. https://dx.doi.org/10.1111/imm.12218.
  24. Zhu J.Y., Pang Z.J., Yu Y.H. Regulation of trophoblast invasion: the role of matrix metalloproteinases. Rev. Obstet. Gynecol. 2012; 5(3-4): e137-43.
  25. Tseng J.J., Chou M.M. Differential expression of growth-, angiogenesis- and invasion-related factors in the development of placenta accreta. Taiwan. J. Obstet. Gynecol. 2006; 45(2): 100-6. https://dx.doi.org/10.1016/S1028-4559(09)60205-9.
  26. Лукашевич А.А., Аксененко В.А., Дубовой А.А. Способ прогнозирования врастания плаценты при беременности. Патент на изобретение RU 2679641 C1, 12.02.2019. Заявка № 2018113887 от 16.04.2018. [Lukashevich A.A., Aksenenko V.A, Dubovoj A.A. Method for predicting placenta growth during pregnancy. Patent for the invention of RU 2679641 C1, 12.02.2019. Application No. 2018113887 dated 16.04.2018. (in Russian)].
  27. Jaffe R., DuBeshter B., Sherer D.M., Thompson E.A., Woods J.R. Failure of methotrexate treatment for term placenta percreta. Am. J. Obstet. Gynecol. 1994; 171(2): 558-9. https://dx.doi.org/10.1016/0002-9378(94)90300-x.
  28. Weckstein L.N., Masserman J.S.H., Garite T.J. Placenta accreta: A problem of increasing clinical significance. Obstet. Gynecol. 1986; 69(3, Pt2): 480-2.
  29. Palacios Jaraquemada J.M., Pesaresi M., Nassif J.C., Hermosid S. Anterior placenta percreta: Surgical approach, hemostasis and uterine repair. Acta Obstet. Gynecol. Scand. 2004; 83(8): 738-44. https://dx.doi.org/10.1111/j.0001-6349.2004.00517.x.
  30. Chandraharan E., Rao S., Belli A.M., Arulkumaran S. The Triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. Int. J. Gynaecol. Obstet. 2012; 117(2): 191-4. https://dx.doi.org/10.1016/j.ijgo.2011.12.005.
  31. Курцер М.А., Бреслав И.Ю., Григорян А.М., Латышкевич О.А. Опыт использования временной баллонной окклюзии общих подвздошных артерий при органосохраняющих операциях у пациенток с врастанием плаценты. Акушерство и гинекология. 2013; 7: 80-4. [Kurtser M.A., Breslav I.Yu., Grigoryan A.M., Latyshkevich O.A. Experience with temporary balloon occlusion of the common iliac arteries in patients with placenta increta during organsparing operations. Obstetrics and Gynegology. 2013; 7: 80-4. (in Russian)].
  32. Курцер М.А., Савельева Г.М., Бреслав И.Ю. Способ консервативного хиругического лечения при родоразрешении пациенток с врастанием плаценты. Патент на изобретение RU 2578183 C1, 20.03.2016. Заявка №2015104592/14 от 12.02.2015. [Kurtser M.A., Saveleva G.M., Breslav I.Yu. Method for conservative surgery in patients with considerable placenta. Patent for the invention RU 2578183 C1, 20.03.2016. Application No. 2015104592/14 dated 12.02.2015. (in Russian)].
  33. Шмаков Р.Г., Чупрынин В.Д., Виницкий А.А. Комплексный компрессионный гемостаз при выполнении органосохраняющего оперативного родоразрешения у пациенток с врастанием плаценты. Патент на изобретение RU 2627633 C, 09.08.2017. Заявка № 2016148856 от 13.12.2016. [Shmakov R.G., Chuprynin V.D., Vinitskij A.A. Integrated compression hemostasis during organ preserving operative delivery in patients with placentar ingrowth. Patent for the invention RU 2627633 C, 09.08.2017. Application No. 2016148856 dated 13.12.2016. (in Russian)].
  34. Шмаков Р.Г., Чупрынин В.Д., Виницкий А.А. Способ двухуровневого гемостаза при выполнении органосохраняющего оперативного родоразрешения у пациенток с врастанием плаценты. Патент на изобретение RU 2626984 C, 02.08.2017. Заявка №2016139121 от 05.10.2016. [Shmakov R.G., Chuprynin V.D., Vinitskij A.A. Method fortwo-level hemostasis during organo-preserving operative delivery in patients with placenta ingrowth. Patent for the invention RU 2626984 C, 02.08.2017. Application No. 2016139121 dated 05.10.2016. (in Russian)].
  35. Шмаков Р. Г., Чупрынин В.Д., Кан Н.Е., Тютюнник В Л., Виницкий А.А. Способ временной окклюзии общих подвздошных артерий при выполнении органосохраняющего оперативного родоразрешения у пациенток с врастанием плаценты. Патент на изобретение RU 2625286 C1, 12.07.2017. Заявка №2016138106 от 26.09.2016. [Shmakov R.G., Chuprynin V.D., Kan N.E., Tyutyunnik V.L.,Vinitskij A.A. Method for temporary occlusion of common iliac arteries during organpreserving operative delivery in patients with placentar ingrowth. Patent for the invention RU 2625286 C1, 12.07.2017. Application No. 2016138106 dated 26.09.2016. (in Russian)].
  36. Шмаков Р.Г., Чупрынин В Д., Приходько А.М. Способ органосохраняющего оперативного родоразрешения у пациенток с врастанием плаценты. Патент на изобретение RU 2706530 C1, 19.11.2019. Заявка №2019119188 от 20.06.2019. [Shmakov R.G., Chuprynin V.D., Prikhodko A.M. Method of organ-preserving surgical delivery in patients with placenta ingrowth. Patent for the invention RU 2706530 C1, 19.11.2019. Application No. 2019119188 dated 20.06.2019. (in Russian)].
  37. Либова Т.А., Аракелян Б.В., Резник В.А., Рухляда Н.Н., Рязанова О.В., Прохорович Т.И. Способ уменьшения объема кровопотери при врастании плаценты. Патент на изобретение RU 2698051 C1, 21.08.2019. Заявка №2018135938 от 10.10.2018. [Libova T.A., Arakelyan B.V., Reznik V.A., Rukhlyada N.N., Ryazanova O.V., Prokhorovich T.I. Method for reducing blood loss associated with placenta ingrowth. Patent for the invention RU 2698051 C1, 21.08.2019. Application No. 2018135938 dated 10.10.2018. (in Russian)].
  38. Куликов И.А., Белоусова Т.Н., Соваев Н.И., Плахотина Е.Н., Милютина Е.Р., Павлютина К.М., Латышев Р.В. Способ оперативного родоразрешения пациенток с врастанием плаценты в рубец на матке с использованием турникетного гемостаза. Патент на изобретение RU 2708369 C1, 05.12.2019. Заявка №2019112811 от 26.04.2019.[Kulikov I.A., Belousova T.N., Sovaev N.I., Plakhotina E.N., Milyutina E.R., Pavlyutina K.M., Latyshev R.V. Method of operative delivery of patientswith ingrowth of placenta into tripe on uterus with tourniquet hemostasis. Patent for the invention RU 2708369 C1, 05.12.2019. Application No. 2019112811 dated 26.04.2019. (in Russian)].
  39. Куликов И.А., Белоусова Т.Н., Соваев Н.И., Плахотина Е.Н., Мусаева С.В., Павлютина К.С., Петров А.Е. Способ оперативного родоразрешения пациенток с врастанием плаценты в рубец на матке. Патент на изобретение RU 2706368 C1, 18.11.2019. Заявка №2019118817 от 18.06.2019. [Kulikov I.A., Belousova T.N., Sovaev N.I., Plakhotina E.N., Musaeva S.V., Pavlyutina K.M., Petrov A.E. Method of operative delivery of patients with ingrown placenta in uterus scar. Patent for the invention RU 2706368 C1, 18.11.2019. Application No. 2019118817 dated 18.06.2019. (in Russian)].
  40. Рокотянская Е.А., Сытова Л.А., Панова И.А., Малышкина А.И. Тренажер матки для обучения навыкам проведения операции при врастании плаценты и хирургического гемостаза при послеродовом кровотечении. Патент на полезную модель 198996 U1, 06.08.2020. Заявка №2019140802 от 10.12.2019. [Rokotyanskaya E.A., Sytova L.A., Panova I.A., Malyshkina A.I. Uterine trainer for teaching the skills of performing surgery for ingrown placenta and surgical hemostasis in postpartum hemorrhage. Utility Model Patent 198996 U1, 06.08.2020. Application 2019140802 dated 10.12.2019. (in Russian)].

Received 21.01.2021

Accepted 27.01.2021

About the Authors

Olga I. Lisitsyna, Resident, Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation. E-mail: o_yazykova@inbox.ru. ORCID: 0000-0002-7775-3508. 4, Oparina str., Moscow, 117997, Russia.
Natalia V. Nizyaeva, Cand. of Sci. (Med.), Senior Researcher, the 2nd Pathology Department, Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation. E-mail: niziaeva@gmail.com. ORCID: 0000-0001-5592-5690.
4, Oparina str., Moscow, 117997, Russia.
Alexandra A. Miheeva, Graduate student, Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology,
Ministry of Health of the Russian Federation. E-mail: shuratora@mail.ru. 4, Oparina str., Moscow, 117997, Russia.

For citation: Lisitsyna O.I., Nizyaeva N.V., Mikheeva A.A. Placenta increta: Evolution of knowledge and skills.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2021; 6: 34-40 (in Russian)
https://dx.doi.org/10.18565/aig.2021.6.34-40

Similar Articles

№11 / 2023
Umanskiy M.N., Chernobabova T.V., Evseev A.V., Baranov A.P., Berezhnaya E.V.
Successful organ-preserving delivery of a pregnant woman with placenta previa and placenta increta at 41 weeks of gestation
№3 / 2023
Umanskiy M.N., Khvalina T.V., Bushtyrev A.V., Berezhnaya E.V.
Management of placenta increta at delivery: our experience
№8 / 2023
Omarova Kh.M., Omarova R.G., Khashaeva T.Kh.-M., Magomedova I.Kh.
Assessment of the state of the fetus by dopplerometry in pregnant women with placenta increta
№2 / 2024
Alieva P.M., Dumanovskaya M.R., Solopova A.E., Smetnik A.A., Chuprynin V.D., Pavlovich S.V.
The features of the course of retrocervical endometriosis
№8 / 2023
Shchegolev A.I., Tumanova U.N. Serov V.N.
The role of the placenta in the development of neonatal brain lesions
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.